VEGF-D has been investigated previously primarily in patients with LAM but the underlying mechanism leading to elevated VEGF-D in patients with angiomyolipomas and pulmonary LAM remains unknown. This evidence concerns the gene VEGFD and lymphangioleiomyomatosis.